|
1H9H
COMPLEX OF EETI-II WITH PORCINE TRYPSIN
Deposited 2001-03-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain I
1–30(30 aa)
|
Mutation:YES
|
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;pH 6.70
|
Resolution 1.50 Å
R-free 0.276
|
|
1H9I
COMPLEX OF EETI-II MUTANT WITH PORCINE TRYPSIN
Deposited 2001-03-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain I
1–30(30 aa)
|
Mutation:YES
|
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;pH 6.70
|
Resolution 1.90 Å
R-free 0.175
|
|
1W7Z
Crystal structure of the free (uncomplexed) Ecballium elaterium trypsin inhibitor (EETI-II)
Deposited 2004-09-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–31(31 aa)
Chain B
1–31(31 aa)
Chain C
1–31(31 aa)
Chain D
1–31(31 aa)
Chain E
1–31(31 aa)
Chain F
1–31(31 aa)
|
Not recorded
|
NA SODIUM ION × 3
FMT FORMIC ACID × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;2M NA-FORMATE 0.1 M NA-ACETATE PH 4.6
|
Resolution 1.67 Å
R-free 0.235
|
|
1W7Z
Crystal structure of the free (uncomplexed) Ecballium elaterium trypsin inhibitor (EETI-II)
Deposited 2004-09-14
|
Different construct
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain G
1–31(31 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;2M NA-FORMATE 0.1 M NA-ACETATE PH 4.6
|
Resolution 1.67 Å
R-free 0.235
|
|
1W7Z
Crystal structure of the free (uncomplexed) Ecballium elaterium trypsin inhibitor (EETI-II)
Deposited 2004-09-14
|
Different construct
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain H
1–31(31 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;2M NA-FORMATE 0.1 M NA-ACETATE PH 4.6
|
Resolution 1.67 Å
R-free 0.235
|
|
2C4B
Inhibitor cystine knot protein McoEeTI fused to the catalytically inactive barnase mutant H102A
Deposited 2005-10-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
16–29(14 aa)
|
Mutation:YES
|
2PE NONAETHYLENE GLYCOL × 2
GOL GLYCEROL × 1
EDO 1,2-ETHANEDIOL × 4
FMT FORMIC ACID × 2
SO4 SULFATE ION × 7
UNX UNKNOWN LIGAND × 15
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;1.3 M AMMONIUM SULPHATE, 7% PEG400 (V/V), 0.1 M MES PH 6.5 AS RESERVOIR SOLUTION. DROPLETS MIXED FROM 8 UL PROTEIN (30 MG/ML) AND 4 UL RESERVOIR. SITTING DROP VAPOR DIFFUSION. 4 DEG. C.
|
Resolution 1.30 Å
R-free 0.164
|
|
2C4B
Inhibitor cystine knot protein McoEeTI fused to the catalytically inactive barnase mutant H102A
Deposited 2005-10-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
16–29(14 aa)
|
Mutation:YES
|
2PE NONAETHYLENE GLYCOL × 2
EDO 1,2-ETHANEDIOL × 6
FMT FORMIC ACID × 1
SO4 SULFATE ION × 10
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;1.3 M AMMONIUM SULPHATE, 7% PEG400 (V/V), 0.1 M MES PH 6.5 AS RESERVOIR SOLUTION. DROPLETS MIXED FROM 8 UL PROTEIN (30 MG/ML) AND 4 UL RESERVOIR. SITTING DROP VAPOR DIFFUSION. 4 DEG. C.
|
Resolution 1.30 Å
R-free 0.164
|
|
2ETI
USE OF RESTRAINED MOLECULAR DYNAMICS IN WATER TO DETERMINE THREE-DIMENSIONAL PROTEIN STRUCTURE: PREDICTION OF THE THREE-DIMENSIONAL STRUCTURE OF ECBALLIUM ELATERIUM TRYPSIN INHIBITOR II
Deposited 1991-07-15
|
Different experimental conditions
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–28(28 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
mmCIF provides none of the parsed conditions
|
Resolution not provided
|
|
2LET
AN 1H NMR DETERMINATION OF THE THREE DIMENSIONAL STRUCTURES OF MIRROR IMAGE FORMS OF A LEU-5 VARIANT OF THE TRYPSIN INHIBITOR ECBALLIUM ELATERIUM (EETI-II)
Deposited 1994-01-04
|
Different experimental conditions
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–28(28 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
mmCIF provides none of the parsed conditions
|
Resolution not provided
|